Does USTEKINUMAB Cause Nasopharyngitis? 2,730 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,730 reports of Nasopharyngitis have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 3.2% of all adverse event reports for USTEKINUMAB.
2,730
Reports of Nasopharyngitis with USTEKINUMAB
3.2%
of all USTEKINUMAB reports
1,168
Deaths
1,542
Hospitalizations
How Dangerous Is Nasopharyngitis From USTEKINUMAB?
Of the 2,730 reports, 1,168 (42.8%) resulted in death, 1,542 (56.5%) required hospitalization, and 1,278 (46.8%) were considered life-threatening.
Is Nasopharyngitis Listed in the Official Label?
Yes, Nasopharyngitis is listed as a known adverse reaction in the official FDA drug label for USTEKINUMAB.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Nasopharyngitis?
ADALIMUMAB (13,753)
ETANERCEPT (12,421)
METHOTREXATE (8,046)
TOFACITINIB (7,781)
SECUKINUMAB (7,022)
TOCILIZUMAB (6,664)
RITUXIMAB (6,321)
ABATACEPT (6,143)
INFLIXIMAB (5,353)
CERTOLIZUMAB PEGOL (5,295)
Which USTEKINUMAB Alternatives Have Lower Nasopharyngitis Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE